These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
101 related items for PubMed ID: 22209511
1. POM-1 metallo-β-lactamase-producing Pseudomonas otitidis isolate from a patient with chronic otitis media. Lee K, Kim CK, Yong D, Yum JH, Chung MH, Chong Y, Thaller MC, Rossolini GM. Diagn Microbiol Infect Dis; 2012 Mar; 72(3):295-6. PubMed ID: 22209511 [No Abstract] [Full Text] [Related]
2. A clinicomicrobiological study on the importance of pseudomonas in nosocomially infected ICU patients, with special reference to metallo beta1-lactamase production. Sarkar B, Biswas D, Prasad R, Sharma JP. Indian J Pathol Microbiol; 2006 Jan; 49(1):44-8. PubMed ID: 16625977 [Abstract] [Full Text] [Related]
3. First report of the carbapenem-resistant Pseudomonas aeruginosa producing IMP-7 metallo-beta-lactamase in Slovakia. Ohlasova D, Kmet V, Niks M. Int J Antimicrob Agents; 2007 Oct; 30(4):370-1. PubMed ID: 17709230 [No Abstract] [Full Text] [Related]
4. Two non-otic cases of POM-1 metallo-β-lactamase-producing Pseudomonas otitidis infection: Necrotizing fasciitis and pan-peritonitis. Kim D, Hong SK, Seo YH, Kim MS, Kim HS, Yong D, Jeong SH, Lee K, Chong Y. J Glob Antimicrob Resist; 2016 Dec; 7():157-158. PubMed ID: 27835844 [No Abstract] [Full Text] [Related]
5. Metallo-beta-lactamase-producing Pseudomonas aeruginosa isolates in Tunisia. Mansour W, Poirel L, Bettaieb D, Bouallegue O, Boujaafar N, Nordmann P. Diagn Microbiol Infect Dis; 2009 Aug; 64(4):458-61. PubMed ID: 19631102 [Abstract] [Full Text] [Related]
6. Molecular epidemiology of VIM-4 metallo-beta-lactamase-producing Pseudomonas sp. isolates in Hungary. Libisch B, Muzslay M, Gacs M, Minárovits J, Knausz M, Watine J, Ternák G, Kenéz E, Kustos I, Rókusz L, Széles K, Balogh B, Füzi M. Antimicrob Agents Chemother; 2006 Dec; 50(12):4220-3. PubMed ID: 17000739 [Abstract] [Full Text] [Related]
7. In vitro synergy studies based on tazobactam/piperacillin against clinical isolates of metallo-beta-lactamase-producing Pseudomonas aeruginosa. Fujimura S, Takane H, Nakano Y, Watanabe A. J Antimicrob Chemother; 2009 Nov; 64(5):1115-6. PubMed ID: 19744981 [No Abstract] [Full Text] [Related]
8. A Pseudomonas aeruginosa isolate producing the GES-5 extended-spectrum beta-lactamase. Wang C, Cai P, Chang D, Mi Z. J Antimicrob Chemother; 2006 Jun; 57(6):1261-2. PubMed ID: 16617065 [No Abstract] [Full Text] [Related]
9. Detection of VIM-5 metallo-beta-lactamase in a Pseudomonas aeruginosa clinical isolate from Turkey. Bahar G, Mazzariol A, Koncan R, Mert A, Fontana R, Rossolini GM, Cornaglia G. J Antimicrob Chemother; 2004 Jul; 54(1):282-3. PubMed ID: 15190017 [No Abstract] [Full Text] [Related]
10. VIM-5 metallo-beta-lactamase-producing Pseudomonas putida from Turkey. Poirel L, Yakupoğullari Y, Kizirgil A, Dogukan M, Nordmann P. Int J Antimicrob Agents; 2009 Mar; 33(3):287. PubMed ID: 18805676 [No Abstract] [Full Text] [Related]
11. IMP-13-producing Pseudomonas monteilii recovered in a hospital environment. Bogaerts P, Bouchahrouf W, Lissoir B, Denis O, Glupczynski Y. J Antimicrob Chemother; 2011 Oct; 66(10):2434-5. PubMed ID: 21764825 [No Abstract] [Full Text] [Related]
12. Novel variant (bla(VIM-11)) of the metallo-{beta}-lactamase bla(VIM) family in a GES-1 extended-spectrum-{beta}-lactamase-producing Pseudomonas aeruginosa clinical isolate in Argentina. Pasteran F, Faccone D, Petroni A, Rapoport M, Galas M, Vázquez M, Procopio A. Antimicrob Agents Chemother; 2005 Jan; 49(1):474-5. PubMed ID: 15616342 [No Abstract] [Full Text] [Related]
13. Detection of metallo-beta-lactamase-producing Pseudomonas aeruginosa strains isolated from burn patients in Ahwaz, Iran. Khosravi AD, Mihani F. Diagn Microbiol Infect Dis; 2008 Jan; 60(1):125-8. PubMed ID: 17900848 [Abstract] [Full Text] [Related]
14. Multidrug-resistant Pseudomonas aeruginosa isolate co-expressing extended-spectrum beta-lactamase PER-1 and metallo-beta-lactamase VIM-2 from Turkey. Yakupogullari Y, Poirel L, Bernabeu S, Kizirgil A, Nordmann P. J Antimicrob Chemother; 2008 Jan; 61(1):221-2. PubMed ID: 17981831 [No Abstract] [Full Text] [Related]
15. Clusters of infection due to metallo-β-lactamase-producing Pseudomonas aeruginosa in stem cell transplant and haematology units. Paez J, Levin AS, Fu L, Basso M, Fonseca GH, Dulley FL, Rossi F, Guimarães T, Costa SF. J Hosp Infect; 2011 Jan; 77(1):76-7. PubMed ID: 21030111 [No Abstract] [Full Text] [Related]
16. Isolation of an extended spectrum beta-lactamase producing Pseudomonas aeruginosa from a patient in a Sydney hospital. Bell SM, Pham JN, Gatus BJ, Poirel L, Nordmann P. Pathology; 2007 Feb; 39(1):189-90. PubMed ID: 17365844 [No Abstract] [Full Text] [Related]
17. Pseudomonas aeruginosa infection in cystic fibrosis caused by an epidemic metallo-β-lactamase-producing clone with a heterogeneous carbapenem resistance phenotype. Pollini S, Fiscarelli E, Mugnaioli C, Di Pilato V, Ricciotti G, Neri AS, Rossolini GM. Clin Microbiol Infect; 2011 Aug; 17(8):1272-5. PubMed ID: 21375657 [Abstract] [Full Text] [Related]
18. Outbreak of carbapenem-resistant Pseudomonas aeruginosa producing SPM-1 metallo-{beta}-lactamase in a teaching hospital in southern Brazil. Zavascki AP, Gaspareto PB, Martins AF, Gonçalves AL, Barth AL. J Antimicrob Chemother; 2005 Dec; 56(6):1148-51. PubMed ID: 16239284 [Abstract] [Full Text] [Related]
19. Outbreak of Pseudomonas aeruginosa producing IMP-9-type metallo-beta-lactamase in Guangzhou, China. Chao Z, Xiao-Feng W, Dan-Hong S, Jin-Ping Y, Nan-Shan Z. Int J Antimicrob Agents; 2008 Oct; 32(4):363-5. PubMed ID: 18619819 [No Abstract] [Full Text] [Related]
20. Silent spread of IMP-13-producing Pseudomonas aeruginosa belonging to sequence type 621 in Belgium. Naas T, Bogaerts P, Kostyanev T, Cuzon G, Huang TD, Ozsu S, Nordmann P, Glupczynski Y. J Antimicrob Chemother; 2011 Sep; 66(9):2178-9. PubMed ID: 21693463 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]